Balchem (NASDAQ:BCPC) Issues Earnings Results

Balchem (NASDAQ:BCPC) released its earnings results on Friday. The basic materials company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08), Zacks reports. Balchem had a net margin of 12.90% and a return on equity of 10.99%.

Balchem Trading Up 1.0 %

NASDAQ:BCPC traded up $1.69 during midday trading on Friday, hitting $163.03. 56,661 shares of the company traded hands, compared to its average volume of 123,579. The firm’s fifty day moving average is $162.44 and its 200-day moving average is $169.32. Balchem has a 12-month low of $137.69 and a 12-month high of $186.03. The firm has a market capitalization of $5.30 billion, a P/E ratio of 43.87, a P/E/G ratio of 4.41 and a beta of 0.69. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21.

Balchem Increases Dividend

The company also recently disclosed an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were issued a dividend of $0.87 per share. This represents a dividend yield of 0.4%. This is a boost from Balchem’s previous annual dividend of $0.79. The ex-dividend date was Thursday, December 26th. Balchem’s dividend payout ratio is 23.39%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on BCPC shares. HC Wainwright lifted their price target on shares of Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a report on Monday, November 4th. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.